The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of pre-transplant JAK 1/2 inhibitors on outcomes of myelofibrosis patients who receive allogeneic stem cell transplant.
 
Kathleen Miller
No Relationships to Disclose
 
Gabriela Hobbs
No Relationships to Disclose
 
Vincent T. Ho
No Relationships to Disclose
 
Shuli Li
No Relationships to Disclose
 
Yi-Bin Albert Chen
Honoraria - Bayer; Millennium
Consulting or Advisory Role - EnGeneIC; Insys Therapeutics; Jazz Pharmaceuticals; Magenta Therapeutics; Regimmune; Seagen; Takeda; Takeda
Research Funding - Bayer; Celgene; Novartis; Seagen